US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

706.36

+20.553.00%

Number of Gainers:75

Number of Losers:72

Number of Flat:7

PE:- -

High:707.30

Open:685.68

Low:683.13

Close:685.75

Volume:166.68M

Turnover:5.58B

Market Cap:492.23B

Float Cap:373.76B

Loading ...

Oppenheimer Remains a Buy on SentinelOne (S)

Press Release: Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign

Milestone Scientific Q2 Revenue Rises 22% on Medical Segment Growth, Reaffirms 2026 Outlook

Analysts’ Opinions Are Mixed on These Technology Stocks: Braze (BRZE), DLocal (DLO) and Stoneco (STNE)

Citigroup CEO backs Clarity Act but warns stablecoin rewards could hurt banks

Outlook Therapeutics Q3 Net Loss Narrows Slightly as Costs Drop

A Workday Takeover Bid Could End the Software Selloff

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)

Acurx Pharmaceuticals Q2 EPS $(0.53) Misses $(0.37) Estimate

Benzinga Earnings

Acurx Pharmaceuticals Q2 EPS USD -0.53

THOMSON REUTERS

Press Release: Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 Results and Provides Business Update

Kanen Wealth Management Llc - Calls for Zevia Board to Establish Special Committee and Retain Financial Advisor

THOMSON REUTERS

Kanen Wealth Management Calls for Sale of Zevia to Maximize Shareholder Value

THOMSON REUTERS

Kanen Wealth Management Llc - Estimates Zevia Sale Value at $2.75-$3.75 Per Share After Tax Receivable Agreement Deduction

THOMSON REUTERS

How CFO of Baby Wipes Maker Honest Revamped Its Finance Office

Analysts Offer Insights on Utilities Companies: AGL Energy (OtherAGLNF) and NextNRG (NXXT)

Intapp FY26 Net Loss Widens to $41.31 Million; Revenue Rises 15% to $577.81 Million

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)

HighTide Therapeutics Sets Board Meeting to Approve Interim Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4539/news?page=33"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":706.298,"timestamp":1787679306472,"preClose":685.7458,"halted":0,"volume":166682958,"delay":0,"changeRate":0.029971,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":20.552185,"latestTime":"08-25 13:35:06 EDT","open":685.6775,"high":707.3044,"low":683.1322,"amount":5579183965.471553,"amplitude":0.035249,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.436531,"peRate":156.391987,"turnoverRate":0.012931,"increases":74,"decrements":72,"flats":5,"marketCap":492225694866.1875,"floatMarketCap":373755510373.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":707.3044,"amplitude":0.035249,"preClose":685.7458,"low":683.1322,"pbRate":"5.436531","latestPrice":706.3622,"volume":166678790,"delay":0,"open":685.6775,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":655.4622,"twentyDayClose":704.4272,"sixtyDayClose":779.4826,"secType":"PLATE","market":"US","turnoverRate":0.012931,"peRate":156.391987,"marketCap":492225694866.1875,"floatMarketCap":373755510373.25,"timestamp":1787679306310,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":75,"down":72,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:33,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659014947","title":"Oppenheimer Remains a Buy on SentinelOne (S)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659014947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659014947?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:18","pubTimestamp":1786709891,"startTime":"0","endTime":"0","summary":"In a report released today, Ittai Kidron from Oppenheimer maintained a Buy rating on SentinelOne, with a price target of $27.00. Kidron covers the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-sentinelone-s-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-sentinelone-s-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4539","OPY","BK4097","BK4585","LU2286300806.USD","BK4127","S","BK4561","BK4560"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659146722","title":"Press Release: Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659146722","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659146722?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:01","pubTimestamp":1786708860,"startTime":"0","endTime":"0","summary":"placement financing. On May 18, 2026, Quince completed a stock-for-stock. merger to acquire Orphai, a clinical-stage biotechnology company,bringing Orphai's lead program, LAM-001, an inhaled formulation of. rapamycin , into the pipeline. LAM-001 is being. developed for the treatment of serious, underserved pulmonary diseases,.Concurrent with the acquisition, Quince entered into a definitive. agreement for a private placement financing with gross upfront proceeds. of $115 million, yielding net proceeds of $103.6 million after deducting. placement agent and other offering expenses of $11.4 million, for the. purchase of shares of Series C non-voting convertible preferred stock and. up to an additional $83 million upon the exercise of warrants (including","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATS","LENZ","BK4139","BK4539","QNCX","SAPH","BK4007","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659141595","title":"Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2659141595","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659141595?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:00","pubTimestamp":1786708800,"startTime":"0","endTime":"0","summary":"- Completed quarter with $26.9 million in cash and restricted cash - Key U.S. patent was awarded, protecting exclusivity of stenoparib when used with the stenoparib-specific DRP companion diagnostic i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345276/0/en/allarity-therapeutics-reports-second-quarter-2026-results-and-completion-of-the-phase-3-ready-stenoparib-manufacturing-campaign.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK4539","LENZ","BK4503","API","BK4023","ALLR","PLTM","CLIA","IDNA","BK4139","BK4551","CDMO","BK4007","NVIB","BMED","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659463741","title":"Milestone Scientific Q2 Revenue Rises 22% on Medical Segment Growth, Reaffirms 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659463741","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659463741?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:42","pubTimestamp":1786707736,"startTime":"0","endTime":"0","summary":"Milestone Scientific Q2 revenue rises 22% on medical segment growth, reaffirms 2026 outlookOverviewMedical device maker's Q2 revenue rose 22% yr/yr, driven by dental and medical segment growthMedical ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLSS","RNXT","BK4539","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659146513","title":"Analysts’ Opinions Are Mixed on These Technology Stocks: Braze (BRZE), DLocal (DLO) and Stoneco (STNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659146513","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659146513?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:40","pubTimestamp":1786707615,"startTime":"0","endTime":"0","summary":"Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Braze (BRZE), DLocal (DLO) and Stoneco (STNE). Bra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-technology-stocks-braze-brze-dlocal-dlo-and-stoneco-stne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-technology-stocks-braze-brze-dlocal-dlo-and-stoneco-stne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2931357623.SGD","LU0274383776.USD","ARTY","BK4563","BK4227","BK4566","BK4023","BRZE","LU2089985449.USD","LU0572108347.SGD","DLO","BK4539","LU0072463663.USD","BK4613","BK4585","STNE","BK4535","TECS","BK4106","BK4588","LU0788109048.HKD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145014","title":"Citigroup CEO backs Clarity Act but warns stablecoin rewards could hurt banks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145014","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145014?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:28","pubTimestamp":1786706925,"startTime":"0","endTime":"0","summary":"Citigroup CEO Jane Fraser has backed passage of the CLARITY Act while continuing to push for changes to its stablecoin reward rules, keeping the banking industry’s main concern with the crypto bill alive ahead of a Senate procedural vote expected next month.Citigroup CEO Jane Fraser supports passing the CLARITY Act but wants changes to its stablecoin reward rules.Fraser warned that stablecoin rewards could pull deposits from banks and reduce their ability to provide credit.A Senate compromise would ban rewards for simply holding stablecoins while allowing incentives tied to payments and transactions.Fraser told Fox Business on Thursday that Citigroup still wants lawmakers to improve parts of the legislation, but she supports getting a workable version through Congress because she believes the bill would benefit the financial system.Her support puts Citigroup in a less confrontational position than some other large banks, even as Fraser shares their concern over whether crypto platforms","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/citigroup-ceo-backs-clarity-act-but-warns-stablecoin-rewards-could-hurt-banks/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/citigroup-ceo-backs-clarity-act-but-warns-stablecoin-rewards-could-hurt-banks/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["ICOI","LU0477156953.USD","BK4585","BK4539","DAPP","FTXO","CRPT","BLCK","LU0203345920.USD","CONX","LU0203347892.USD","LU1201861249.SGD","COIG","COII","BK4588","COIA","LU1267930227.SGD","COIO","BK4559","LU0128525689.USD","LU0130102774.USD","LU2462157665.USD","LU1074936037.SGD","LU0098860793.USD","BK4504","BK4566","LU1506573853.SGD","COIN","FDIG","LU0320765646.SGD","LU2236285917.USD","LU0130517989.USD","LU0314106906.USD","IE00BSNM7G36.USD","LU0980610538.SGD","LU1668664300.SGD","BITQ","LU1162221912.USD","COIW","CONL","TFNS","LU1244550494.USD","LU2125154778.USD","IYF","BK4554","LU2360032135.SGD","BK4112","LU1244550577.SGD","BK4600","LU2125154935.USD","C","LU2456880835.USD","LU0072461881.USD","LU1366192091.USD","LU0310800965.SGD","LU1244550221.USD","FINX","CONI","BK4516","BKCH","BK4551","LU1861559042.SGD","LU0106831901.USD","LU1861558580.USD","BK4535","LU0162691827.USD","BK4595","BK4534","LU1861220207.SGD","LU0648001328.SGD","LU2417539215.USD","LU0170899867.USD","LU1791807156.HKD","LU1861217088.USD","LU0052756011.USD","BK4207","COYY","CONY","FIAT","BK4596","LU2360107671.USD","IBLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659413145","title":"Outlook Therapeutics Q3 Net Loss Narrows Slightly as Costs Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2659413145","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659413145?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:26","pubTimestamp":1786706773,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics Q3 net loss narrows slightly as costs dropOverviewU.S. biopharmaceutical firm's fiscal Q3 net loss narrowedCompany advancing U.S. launch strategy for LYTENAVA, FDA-approved ophtha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","KOD","BK4505","BK4139","PLRX","OTLK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145468","title":"A Workday Takeover Bid Could End the Software Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145468","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145468?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:22","pubTimestamp":1786706520,"startTime":"0","endTime":"0","summary":"Software shares have slumped this year due to fears of artificial intelligence disruption -- but the worst of the pain could be over for the embattled sector.A takeover of enterprise software develope","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTC","LU0719512351.SGD","WDAY","BK4505","PCOR","LU0082616367.USD","BK4543","GTLB","BK4576","BK4554","LU2506952337.HKD","BK4581","BK4613","BK4539","LU1046421795.USD","LU1721428347.USD","LU2265009873.SGD","LU2362540622.SGD","SG9999014005.SGD","LU1935042991.SGD","LU2362541273.HKD","LU2517655291.USD","LU2517655028.SGD","BK4535","BK4607","BK4548","BK4023","BK4585","LU1861558580.USD","LU2517655374.HKD","LU1923623000.USD","SG9999014013.SGD","BK4547","LU1951198990.SGD","PATX","BK4561","LU0314104364.USD","LU2362541513.USD","PATH","IE00B5949003.HKD","LU1861559042.SGD","LU1691799644.USD","IE0009356076.USD","BK4528","LU1989773731.SGD","BK4551","LU2506952410.USD","LU1235294995.USD","BK4097","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659128145","title":"Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659128145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659128145?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:20","pubTimestamp":1786706410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pharvaris (PHVS), Caribou Biosciences (CRBU) and Ave...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-caribou-biosciences-crbu-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-caribou-biosciences-crbu-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4196","AVAH","BK4139","LABU","XBI","BK4581","CRBU","PHVS","BK4007","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143785","title":"Acurx Pharmaceuticals Q2 EPS $(0.53) Misses $(0.37) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143785","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143785?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:02","pubTimestamp":1786705322,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.37) by 43.24 percent. This is a 71.96 percent increase over losses of $(1.89) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61203893/acurx-pharmaceuticals-q2-eps-0-53-misses-0-37-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659279143","title":"Acurx Pharmaceuticals Q2 EPS USD -0.53","url":"https://stock-news.laohu8.com/highlight/detail?id=2659279143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659279143?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:02","pubTimestamp":1786705321,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLXF09J3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","ACXP","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145854","title":"Press Release: Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145854","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145854?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:01","pubTimestamp":1786705260,"startTime":"0","endTime":"0","summary":"STATEN ISLAND, N.Y., Aug. 14, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc.  , a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the second quarter ended June 30, 2026.Highlights of the second quarter ended June 30, 2026, or in some cases shortly thereafter, include:-- In April 2026, the Company announced the closing of a registered direct. offering of 825,085 shares of its common stock (or pre-funded warrants in. lieu thereof) at a purchase price of $3.03 per share (or pre-funded. warrant in lieu thereof) priced at-the-market under Nasdaq rules. In. addition, in a concurrent private placement, the Company issued. unregistered short-term warrants to purchase up to 1,650,170 shares of. common stock. The short-term warrants have an exercise price of $2.78 per. share, and are immediately exercisable upon issuance and will expire. twenty-four months follo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4539","BK4139","BK4022","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659409143","title":"Kanen Wealth Management Llc - Calls for Zevia Board to Establish Special Committee and Retain Financial Advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2659409143","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659409143?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA8BMKKF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4177","ZVIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143406","title":"Kanen Wealth Management Calls for Sale of Zevia to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143406","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143406?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA8BMKKF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZVIA","BK4177","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143293","title":"Kanen Wealth Management Llc - Estimates Zevia Sale Value at $2.75-$3.75 Per Share After Tax Receivable Agreement Deduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143293","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143293?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA8BMKKF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ZVIA","BK4177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659614318","title":"How CFO of Baby Wipes Maker Honest Revamped Its Finance Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2659614318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659614318?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:50","pubTimestamp":1786704600,"startTime":"0","endTime":"0","summary":"A key learning for me as I went through my first year is, you know what the answer is. You need to just go do it. It's not going to get better. It's not going to get easier. Go do it, and you'll figure out the remaining 20%.-- Kristin BroughtonThe Day Ahead&#128200;  Economic IndicatorsThe Census Bureau reports retail and food-service sales for July.The University of Michigan releases its Consumer Sentiment index for August.Share this email with a friend. ForwardForwarded this email by a friend?Sign Up HereWhat Else Matters to CFOsElon Musk's vision for taking electric vehicles mainstream at Tesla helped make him the world's richest person. Now he's pulling up to the gas pump, WSJ reporters Becky Peterson and Jennifer Hiller write.Last week, SpaceX disclosed plans to build a natural gas power plant in Grimes County, Texas, where the compa","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MKR.USD.CC","BK4539","HNST","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168148","title":"Analysts Offer Insights on Utilities Companies: AGL Energy (OtherAGLNF) and NextNRG (NXXT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168148","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659168148?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:10","pubTimestamp":1786702207,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Utilities sector as 2 analysts just weighed in on AGL Energy (AGLNF) and NextNRG (NXXT) with bullish se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-utilities-companies-agl-energy-otheraglnf-and-nextnrg-nxxt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-utilities-companies-agl-energy-otheraglnf-and-nextnrg-nxxt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","NXXT","BK4539","AGLNF","BK4208","AGL","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659100381","title":"Intapp FY26 Net Loss Widens to $41.31 Million; Revenue Rises 15% to $577.81 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659100381","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659100381?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:05","pubTimestamp":1786701949,"startTime":"0","endTime":"0","summary":"Intapp FY26 net loss widens to $41.31 million; revenue rises 15% to $577.81 millionIntapp posted fiscal 2026 revenue of USD 577.8 million, up 15%, as SaaS revenue climbed 27% to USD 422.8 million.Net ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL82RK7B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","INTA","LU1815336091.USD","BK4539","BK4535","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117015","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117015","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659117015?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:40","pubTimestamp":1786700431,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrod...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-caribou-biosciences-crbu-bristol-myers-squibb-bmy-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-caribou-biosciences-crbu-bristol-myers-squibb-bmy-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096364046.USD","LU1983299246.USD","LU1989771016.USD","SDGR","FTXH","IE0009355771.USD","LU0456855351.SGD","XBI","LU1670710661.SGD","LU0321505868.SGD","LU1670710588.SGD","LU1074936037.SGD","BMY","BK4139","BK4539","LU0321505439.SGD","LU0225284248.USD","XLV","IE00BSNM7G36.USD","LU1430594728.SGD","LU2242652126.USD","BK4007","LU0237698245.USD","LABU","LU1032466523.USD","LU1093756168.USD","LU1291159041.SGD","LU1585245621.USD","LU1571399168.USD","LU2125154778.USD","LU2125154935.USD","LU0306807586.USD","LU0882574055.USD","IHE","LU1261432733.SGD","BK4559","LU1868837300.USD","LU2242646821.SGD","LU0029874061.USD","CRBU","BK4588","LU0985481810.HKD","LU0267386448.USD","LU1093756325.SGD","LU0868494617.USD","LU2596442595.SGD","BK4532","LU1670711040.USD","IE00B2B36J28.USD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659177041","title":"HighTide Therapeutics Sets Board Meeting to Approve Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659177041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659177041?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:29","pubTimestamp":1786699765,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Hightide Therapeutics Inc ( ($HK:2511) ). HighTide Therapeutics Inc. has scheduled a board meeting for August 3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hightide-therapeutics-sets-board-meeting-to-approve-interim-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hightide-therapeutics-sets-board-meeting-to-approve-interim-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":33,"totalSize":1076,"code":"91000000","status":"200"}]}}